#news #biotech Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going .Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going
ntaylor
Tue, 02/23/2021 – 08:13

from FierceBiotech: Biotech https://ift.tt/3uoYpHk